VALN
Valneva SE
NASDAQ · Healthcare · Biotechnology · FR
$6.89
−2.41%Institutional positioning
13F filings over the trailing two quarters
New 6Increased 2Reduced 6Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 2,291,666 | May 15, 2026 |
| NOVO HOLDINGS A/S | Reduced | 1,057,421 | May 15, 2026 |
| GENERAL AMERICAN INVESTORS CO INC | Unchanged | 354,361 | May 1, 2026 |
| WELLS FARGO & COMPANY/MN | Reduced | 78,029 | Jul 8, 2026 |
| MORGAN STANLEY | Reduced | 46,925 | May 15, 2026 |
| IRONWOOD INVESTMENT MANAGEMENT LLC | Unchanged | 25,135 | May 15, 2026 |
| HRT FINANCIAL LP | New Position | 20,847 | May 14, 2026 |
| CITADEL ADVISORS LLC | New Position | 20,294 | Sep 2, 2026 |
| OLD MISSION CAPITAL LLC | New Position | 13,759 | May 15, 2026 |
| VSM WEALTH ADVISORY, LLC | New Position | 10,000 | May 6, 2026 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | Unchanged | 5,000 | Apr 28, 2026 |
| RHUMBLINE ADVISERS | Increased | 1,793 | May 12, 2026 |
| GAMMA INVESTING LLC | Reduced | 1,426 | Apr 6, 2026 |
| STEIGERWALD, GORDON & KOCH INC. | New Position | 1,250 | Apr 28, 2026 |
| UBS GROUP AG | Increased | 782 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings